血液透析血管接取裝置市場：市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033）

當腎臟停止運作時，水會滯留在體內，有害廢物會累積。末期腎病 (ESRD) 患者需要治療以替代衰竭的腎臟功能。

慢性腎臟病（CKD）是一種腎功能在一段時間內下降的疾病。若腎絲球濾過率持續低於60 毫升每分鐘超過3 個月，或尿液白蛋白/肌酸酐比值超過每1 克(g) 肌酸酐(30 mg/g) 含白蛋白30 毫克(mg)，則成為CKD 。

急性腎損傷是腎功能突然、暫時、有時甚至致命的下降。

本報告深入探討了全球血液透析血管通路裝置市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。

目錄

目前市售的血液透析血管通路裝置及競爭狀況

• 洞察關鍵產業趨勢
• 血液透析血管通路裝置的市場總收入及按細分市場劃分的競爭格局
• 有關單位、平均售價和市場價值的詳細數據

全球、區域和國家見解

• 血液透析血管通路器械市場SWOT分析
• 血液透析血管接取設備市場的競爭動態洞察與趨勢
• 按國家/地區劃分的醫療保健系統概覽
• 各國報銷政策
• 各國醫療技術法規現狀

Abstract

Vascular Access Devices for Hemodialysis Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Nephrology and Urology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Vascular Access Devices for Hemodialysis market for the year 2020 and beyond.

End-Stage Renal Disease (ESRD):

Total and permanent kidney failure. When the kidneys fail, the body retains fluid. Harmful wastes build up. A person with ESRD needs treatment to replace the work of the failed kidneys.

Chronic Kidney Disease (CKD):

Any condition that causes reduced kidney function over a period of time. CKD is present when a patient's glomerular filtration rate remains below 60 milliliters per minute for more than 3 months or when a patient's urine albumin-to-creatinine ratio is over 30 milligrams (mg) of albumin for each gram (g) of creatinine (30 mg/g).

Acute Kidney Injury:

Sudden, temporary, and sometimes fatal loss of kidney function.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Vascular Access Devices for Hemodialysis and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Vascular Access Devices for Hemodialysis market revenue by segment and market outlooks from

2015- 2033.

• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Vascular Access Devices for Hemodialysis.
• Competitive dynamics insights and trends provided for Vascular Access Devices for Hemodialysis market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Fresenius SE & Co KGaA, Becton Dickinson and Co, Baxter International Inc, Medtronic Plc, B. Braun Melsungen AG, W. L. Gore & Associates Inc, NIPRO Corp, and others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Vascular Access Devices for Hemodialysis market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Vascular Access Devices for Hemodialysis market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Vascular Access Devices for Hemodialysis market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Vascular Access Devices for Hemodialysis market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Vascular Access Devices for Hemodialysis market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable